RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus

18Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We found that the strain Aspergillus fumigatus var. fumigatus RK95-113 produced a new angiogenesis inhibitor, RK-95113. Spectroscopic analyses identified the structure of RK-95113 as a new fumagillin-related small molecule. RK-95113 preferentially inhibited the growth of human umbilical vein endothelial cells (HUVECs) rather than that of human normal fibroblasts in cell proliferation assays and blocked endothlial cell migration induced by vascular endothelial growth factor (VEGF). © Japan Antibiotics Research Association.

Cite

CITATION STYLE

APA

Asami, Y., Kakeya, H., Okada, G., Toi, M., & Osada, H. (2006). RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus. Journal of Antibiotics, 59(11), 724–728. https://doi.org/10.1038/ja.2006.97

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free